{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:08:06Z","timestamp":1746090486045,"version":"3.38.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","award":["NA","NA"],"award-info":[{"award-number":["NA","NA"]}],"id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03284-9","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T07:21:56Z","timestamp":1741418516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fine-tuning of dopamine receptor signaling with aripiprazole counteracts ketamine\u2019s dissociative action, but not its antidepressant effect"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9311-875X","authenticated-orcid":false,"given":"Daiki","family":"Nakatsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4695-7815","authenticated-orcid":false,"given":"Taro","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Tashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ohnami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-3683","authenticated-orcid":false,"given":"Hirotsugu","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0778-3381","authenticated-orcid":false,"given":"Naoya","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4820-1541","authenticated-orcid":false,"given":"Hidekuni","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-8188","authenticated-orcid":false,"given":"Toshiya","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"3284_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"3284_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","volume":"175","author":"MF Grunebaum","year":"2018","unstructured":"Grunebaum MF, Galfalvy HC, Choo T-H, Keilp JG, Moitra VK, Parris MS, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry. 2018;175:327\u201335.","journal-title":"Am J Psychiatry"},{"key":"3284_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jama.2017.10697","volume":"318","author":"ST Wilkinson","year":"2017","unstructured":"Wilkinson ST, Sanacora G. Considerations on the off-label use of ketamine as a treatment for mood disorders. JAMA. 2017;318:793.","journal-title":"JAMA"},{"key":"3284_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00213-023-06324-8","volume":"240","author":"DS Mathai","year":"2023","unstructured":"Mathai DS, Nayak SM, Yaden DB, Garcia-Romeu A. Reconsidering \u201cdissociation\u201d as a predictor of antidepressant efficacy for esketamine. Psychopharmacology. 2023;240:827\u201336.","journal-title":"Psychopharmacology"},{"key":"3284_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/cap.2022.0086","volume":"33","author":"A Lineham","year":"2023","unstructured":"Lineham A, Avila-Quintero VJ, Bloch MH, Dwyer J. The relationship between acute dissociative effects induced by ketamine and treatment response in adolescent patients with treatment-resistant depression. J Child Adolesc Psychopharmacol. 2023;33:20\u20136.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"3284_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Arch Gen Psychiatry. 1994;51:199.","journal-title":"Arch Gen Psychiatry"},{"key":"3284_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0091-3057(91)90571-I","volume":"40","author":"M Irifune","year":"1991","unstructured":"Irifune M, Shimizu T, Nomoto M. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav. 1991;40:399\u2013407.","journal-title":"Pharmacol Biochem Behav"},{"key":"3284_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3797\/scipharm.0810-11","volume":"76","author":"OV Arruda M de","year":"2008","unstructured":"Arruda M de OV. Activities of the antipsychotic drugs haloperidol and risperidone on behavioural effects induced by ketamine in mice. Sci Pharm. 2008;76:673\u201387.","journal-title":"Sci Pharm"},{"key":"3284_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","volume":"279","author":"Y Li","year":"2015","unstructured":"Li Y, Zhu ZR, Ou BC, Wang YQ, Tan ZB, Deng CM, et al. Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test. Behav Brain Res. 2015;279:100\u20135.","journal-title":"Behav Brain Res"},{"key":"3284_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/JCP.0b013e3182856865","volume":"33","author":"D Zigman","year":"2013","unstructured":"Zigman D, Blier P. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder. J Clin Psychopharmacol. 2013;33:270\u20132.","journal-title":"J Clin Psychopharmacol"},{"key":"3284_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/2045125316675578","volume":"7","author":"\u00c1 L\u00f3pez-D\u00edaz","year":"2017","unstructured":"L\u00f3pez-D\u00edaz \u00c1, Fern\u00e1ndez-Gonz\u00e1lez JL, Luj\u00e1n-Jim\u00e9nez JE, Galiano-Rus S, Guti\u00e9rrez-Rojas L. Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain. Ther Adv Psychopharmacol. 2017;7:137\u201340.","journal-title":"Ther Adv Psychopharmacol"},{"key":"3284_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jcph.122","volume":"53","author":"F Segmiller","year":"2013","unstructured":"Segmiller F, R\u00fcther T, Linhardt A, Padberg F, Berger M, Pogarell O, et al. Repeated S\u2010ketamine infusions in therapy resistant depression: a case series. J Clin Pharmacol. 2013;53:996\u20138.","journal-title":"J Clin Pharmacol"},{"key":"3284_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","volume":"106","author":"W Zheng","year":"2018","unstructured":"Zheng W, Zhou Y-L, Liu W-J, Wang C-Y, Zhan Y-N, Li H-Q, et al. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J Psychiatr Res. 2018;106:61\u20138.","journal-title":"J Psychiatr Res"},{"key":"3284_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 2019;42:205\u201320.","journal-title":"Trends Neurosci"},{"key":"3284_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41386-018-0291-6","volume":"44","author":"J Muir","year":"2019","unstructured":"Muir J, Lopez J, Bagot RC. Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression. Neuropsychopharmacology. 2019;44:1013\u201326.","journal-title":"Neuropsychopharmacology"},{"key":"3284_CR16","doi-asserted-by":"publisher","first-page":"pyu097","DOI":"10.1093\/ijnp\/pyu097","volume":"18","author":"E Fanarioti","year":"2015","unstructured":"Fanarioti E, Mavrikaki M, Panagis G, Mitsacos A, Nomikos GG, Giompres P. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. Int J Neuropsychopharmacol. 2015;18:pyu097.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3284_CR17","doi-asserted-by":"publisher","first-page":"588160","DOI":"10.3389\/fphar.2020.588160","volume":"11","author":"P Devoto","year":"2020","unstructured":"Devoto P, Sagheddu C, Santoni M, Flore G, Saba P, Pistis M, et al. Noradrenergic source of dopamine assessed by microdialysis in the medial prefrontal cortex. Front Pharmacol. 2020;11:588160.","journal-title":"Front Pharmacol"},{"key":"3284_CR18","doi-asserted-by":"publisher","first-page":"16453","DOI":"10.1523\/JNEUROSCI.3177-10.2010","volume":"30","author":"J-L Cao","year":"2010","unstructured":"Cao J-L, Covington HE, Friedman AK, Wilkinson MB, Walsh JJ, Cooper DC, et al. Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J Neurosci. 2010;30:16453\u20138.","journal-title":"J Neurosci"},{"key":"3284_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11713","volume":"493","author":"D Chaudhury","year":"2013","unstructured":"Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature. 2013;493:532\u20136.","journal-title":"Nature"},{"key":"3284_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1124\/jpet.114.213793","volume":"350","author":"K Maeda","year":"2014","unstructured":"Maeda K, Sugino H, Akazawa H, Amada N, Shimada J, Futamura T, et al. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator. J Pharmacol Exp Ther. 2014;350:589\u2013604.","journal-title":"J Pharmacol Exp Ther"},{"key":"3284_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2020","unstructured":"Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704.","journal-title":"Neuropharmacology"},{"key":"3284_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0278-5846(88)90001-2","volume":"12","author":"H Hall","year":"1988","unstructured":"Hall H, K\u00f6hler C, Gawell L, Farde L, Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12:559\u201368.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3284_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00213-008-1069-z","volume":"199","author":"G S\u00f8rensen","year":"2008","unstructured":"S\u00f8rensen G, Sager TN, Petersen JH, Brennum LT, Th\u00f8gersen P, Hee Bengtsen C, et al. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology. 2008;199:37\u201346.","journal-title":"Psychopharmacology"},{"key":"3284_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2016.05.010","volume":"111","author":"EV Gurevich","year":"2016","unstructured":"Gurevich EV, Gainetdinov RR, Gurevich VV. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Pharmacol Res. 2016;111:1\u201316.","journal-title":"Pharmacol Res"},{"key":"3284_CR25","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.2174\/138161209788957528","volume":"15","author":"O Howes","year":"2009","unstructured":"Howes O, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des. 2009;15:2550\u20139.","journal-title":"Curr Pharm Des"},{"key":"3284_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/sj.npp.1301242","volume":"32","author":"O Agid","year":"2007","unstructured":"Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, et al. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response\u2014a double-blind PET study in Schizophrenia. Neuropsychopharmacology. 2007;32:1209\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"3284_CR27","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/mp.2017.213","volume":"23","author":"AC Brumback","year":"2018","unstructured":"Brumback AC, Ellwood IT, Kjaerby C, Iafrati J, Robinson S, Lee AT, et al. Identifying specific prefrontal neurons that contribute to autism-associated abnormalities in physiology and social behavior. Mol Psychiatry. 2018;23:2078\u201389.","journal-title":"Mol Psychiatry"},{"key":"3284_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08168-9","volume":"10","author":"BD Hare","year":"2019","unstructured":"Hare BD, Shinohara R, Liu RJ, Pothula S, DiLeone RJ, Duman RS. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects. Nat Commun. 2019;10:223.","journal-title":"Nat Commun"},{"key":"3284_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1523\/JNEUROSCI.2326-15.2016","volume":"36","author":"JK Dreyer","year":"2016","unstructured":"Dreyer JK, Vander Weele CM, Lovic V, Aragona BJ. Functionally distinct dopamine signals in nucleus accumbens core and shell in the freely moving rat. J Neurosci. 2016;36:98\u2013112.","journal-title":"J Neurosci"},{"key":"3284_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.109.160432","volume":"333","author":"B Kiss","year":"2010","unstructured":"Kiss B, Horv\u00e1th A, N\u00e9methy Z, Schmidt \u00c9, Laszlovszky I, Bugovics G, et al. Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3\/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther. 2010;333:328\u201340.","journal-title":"J Pharmacol Exp Ther"},{"key":"3284_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s002130051049","volume":"145","author":"JH Krystal","year":"1999","unstructured":"Krystal JH, D\u2019Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D, et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology. 1999;145:193\u2013204.","journal-title":"Psychopharmacology"},{"key":"3284_CR32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1017\/S1461145708009814","volume":"12","author":"B Oranje","year":"2009","unstructured":"Oranje B, Gispen-de Wied CC, Westenberg HGM, Kemner C, Verbaten MN, Kahn RS. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. Int J Neuropsychopharmacol. 2009;12:823.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3284_CR33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","volume":"42","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biol Psychiatry. 1997;42:664\u20138.","journal-title":"Biol Psychiatry"},{"key":"3284_CR34","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1007\/s00213-022-06233-2","volume":"239","author":"XM Hart","year":"2022","unstructured":"Hart XM, Hiemke C, Eichentopf L, Lense XM, Clement HW, Conca A, et al. Therapeutic reference range for aripiprazole in Schizophrenia revised: a systematic review and metaanalysis. Psychopharmacology. 2022;239:3377\u201391.","journal-title":"Psychopharmacology"},{"key":"3284_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170:1134\u201342.","journal-title":"Am J Psychiatry"},{"key":"3284_CR36","doi-asserted-by":"publisher","first-page":"eade5397","DOI":"10.1126\/sciadv.ade5397","volume":"9","author":"H Inaba","year":"2023","unstructured":"Inaba H, Li H, Kawatake-Kuno A, Dewa K, Nagai J, Oishi N, et al. GPCR-mediated calcium and cAMP signaling determines psychosocial stress susceptibility and resiliency. Sci Adv. 2023;9:eade5397.","journal-title":"Sci Adv"},{"key":"3284_CR37","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neuron.2023.12.004","volume":"112","author":"H Li","year":"2024","unstructured":"Li H, Kawatake-Kuno A, Inaba H, Miyake Y, Itoh Y, Ueki T, et al. Discrete prefrontal neuronal circuits determine repeated stress-induced behavioral phenotypes in male mice. Neuron. 2024;112:786\u2013804.e8. https:\/\/doi.org\/10.1016\/j.neuron.2023.12.004.","journal-title":"Neuron"},{"key":"3284_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102504","volume":"24","author":"Y Sakai","year":"2021","unstructured":"Sakai Y, Li H, Inaba H, Funayama Y, Ishimori E, Kawatake-Kuno A, et al. Gene-environment interactions mediate stress susceptibility and resilience through the CaMKII\u03b2\/TARP\u03b3-8\/AMPAR pathway. IScience. 2021;24:102504.","journal-title":"IScience"},{"key":"3284_CR39","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nprot.2011.361","volume":"6","author":"SA Golden","year":"2011","unstructured":"Golden SA, Covington HE, Berton O, Russo SJ. A standardized protocol for repeated social defeat stress in mice. Nat Protoc. 2011;6:1183\u201391.","journal-title":"Nat Protoc"},{"key":"3284_CR40","doi-asserted-by":"publisher","first-page":"e182060","DOI":"10.1172\/jci.insight.182060","volume":"9","author":"S Ohnami","year":"2024","unstructured":"Ohnami S, Naito M, Kawase H, Higuchi M, Hasebe S, Takasu K, et al. Brain region-specific neural activation by low-dose opioid promotes social behavior. JCI Insight. 2024;9:e182060.","journal-title":"JCI Insight"},{"key":"3284_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4088\/JCP.13m08852","volume":"76","author":"L-B Wan","year":"2015","unstructured":"Wan L-B, Levitch CF, Perez AM, Brallier JW, Iosifescu DV, Chang LC, et al. Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry. 2015;76:247\u201352.","journal-title":"J Clin Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03284-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03284-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03284-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T07:21:59Z","timestamp":1741418519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03284-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3284"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03284-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DN, YD, SO, RT, KO, and HY are full-time employees of Shionogi & Co., Ltd.. The funder had the following involvement in the study: study design, interpretation of data, writing of the article, and the decision to submit it for publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}